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Background-—It is well known that after menopause women are exposed to a greater cardiovascular risk, but the intracellular
modifications are not properly described. The sodium/proton exchanger (NHE) and the sodium/bicarbonate cotransporter (NBC)
regulate the intracellular pH and, indirectly, the intracellular sodium concentration ([Na+]). There are 2 isoforms of NBC in the heart:
the electrogenic (1Na+/2HCO3 ; NBCe1) and the electroneutral (1Na
+/1HCO3 ; NBCn1). Because NHE and NBCn1 hyperactivity as
well as the NBCe1 decreased activity have been associated with several cardiovascular pathologies, the aim of this study was to
investigate the potential alterations of the alkalinizing transporters during the postmenopausal period.
Methods and Results-—Three-month ovariectomized rats (OVX) were used. The NHE activity and protein expression are
significantly increased in OVX. The NBCe1 activity is diminished, and the NBCn1 activity becomes predominant in OVX rats. p-Akt
levels showed a significant diminution in OVX. Finally, NHE activity in platelets from OVX rats is also higher in comparison to sham
rats, resulting in a potential biomarker of cardiovascular diseases.
Conclusions-—Our results demonstrated for the first time that in the cardiac ventricular myocytes of OVX rats NHE and NBC
isoforms are altered, probably because of the decreased level of p-Akt, compromising the ionic intracellular homeostasis. ( J Am
Heart Assoc. 2019;8:e011066. DOI: 10.1161/JAHA.118.011066.)
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E pidemiological studies show that the incidence ofcardiovascular disease (CVD) is higher in men than in
premenopausal women. The incidence of such events rises
following menopause, suggesting that, because of reduced
estrogen levels after menopause, women lose an important
cardiovascular protective mechanism and are at greater risk
of developing CVD.1-3 It is well known that estrogens have
multiple protective effects on the cardiovascular system.4,5 In
animal models it has been demonstrated that estrogens
reduce cardiac ischemia/reperfusion injury, improving the
functional response after such a protocol,6-8 and mitigate
angiotensin II–induced cardiac hypertrophy in female rats.9
Cardiomyocytes possess 3 different and functional estrogen
receptors (ERs): the 2 classic nuclear ERs (ERa and ERb) and a
G protein–coupled ER known as GPER. ERa and ERb classically
bind estrogen and translocate to the nucleus where they
modulate transcription,10 whereas GPER, which is localized at
the plasma and intracellular membranes, activates several
rapid and nongenomic intracellular signaling cascades.11-14
The sodium/proton exchanger (NHE) and the sodium/
bicarbonate cotransporter (NBC) are the most important
alkalinizing mechanisms in cardiac myocytes.15,16 They not
only regulate the intracellular pH (pHi) but also modulate the
intracellular sodium concentration ([Na+]i) and indirectly,
through sodium/calcium antiporter activity, regulate the
intracellular calcium concentration ([Ca2+]i).
17-20 It has been
fully demonstrated that the overactivation of NHE and NBC is
involved in Na+ and Ca2+ overload,17,20 leading to the
development and progression of several CVD types.21-29
At present, it is known that at least 2 functional isoforms of
NBC exist in ventricular myocytes: the electroneutral (stoi-
chiometry 1Na+/1HCO3 ), called NBCn1, and the electrogenic
(stoichiometry 1Na+/2HCO3 ), called NBCe1.
30 In our labora-
tory we demonstrated that NBCe1 generates an anionic
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current that shortens the action potential duration in both rat
and cat isolated ventricular myocytes.31,32 In addition, NBCe1,
because of its stoichiometry, promotes the influx of less Na+
for each HCO3 . This allowed us and other groups to refer to
this NBC isoform as a “Na+-sparing” mechanism.19,21 Inter-
estingly, it was proposed that NBCe1 could be beneficial for
heart function, and NBCn1 and NHE be harmful for it,
especially when they are overactivated.33 In this regard it was
demonstrated that in spontaneously hypertensive rats (SHR)
the NBCe1 activity is impaired, and this is compensated with
an overexpression of NBCn1. This remodeling of NBC
isoforms could explain, at least in part, the development of
cardiac hypertrophy and the prolongation of the action
potential duration of these rats.21
One of the most important pathways that mediate the
cardiac protective effects of estrogens is the pathway
involving PI3 kinase/Akt signaling.34 However, the specific
intracellular mechanism that generates the protection is not
well known. In this regard, in 2008, Snabaitis et al demon-
strated that Akt-mediated phosphorylation at Ser-648 inhibits
NHE activity during intracellular acidosis.35 Moreover, this
inhibitory phosphorylation is involved in the physiological
cardiac hypertrophy induced by aerobic exercise,36 preventing
the sodium overload observed in the pathologic cardiac
hypertrophy. In addition, we have demonstrated that the
activation of the Akt pathway stimulates NBCe1 activity.37,38
It has been demonstrated that ovariectomized (OVX) rats,
as an animal model of menopause, may exhibit increased
ischemia/reperfusion injury,39,40 cardiac hypertrophy,41 dias-
tolic dysfunction, increase in systolic blood pressure,42-44 and
calcium abnormalities.45,46 However, the mechanisms under-
lying these detrimental phenomena remain to be fully
elucidated. Herein, we describe for the first time that OVX
rats exhibit modifications of the NHE and NBC isoform
activity, which can explain, at least in part, the increased CVD
observed during menopause.
Material and Methods
The authors declare that all supporting data within this article
are available.
Animals
All experiments were performed in accordance with the Guide
for the Care and Use of Laboratory Animals (NIH Publication
No. 85-23, revised 1996) and approved by the Institutional
Animal Care and Use Committee of La Plata University. Three-
month-old female Wistar rats were divided based on com-
puter-generated numbers to achieve randomization and
assigned to undergo either bilateral OVX (20 rats) or a sham
operation (16 rats). The animals were anesthetized with
isoflurane 3% for induction and 1.5% during the surgical
procedure, which consisted of a bilateral removal of the
ovaries. Briefly, a small incision was performed in the middle
part of the abdomen, and the abdominal cavity was accessed
through the linea alba. Adipose tissue was pulled away until
the uterine horn and the ovaries were identified. The ovaric
arteries were ligated, and both ovaries were extracted. The
uterine horns were returned to the peritoneal cavity after the
removal of the ovaries, and the wound was closed using
sterile 4-0 Nylon sutures. (Surgikal Cardiopack Argentina SA,
Buenos Aires, Argentina). The sham operation was performed
by exposing the ovaries without isolation. Successful ovariec-
tomy was confirmed by uterine atrophy. Thirty days after the
surgery the animals were euthanized and their hearts and
blood were used for different experiments. The physiological
parameters (body weight and systolic blood pressure) were
measured before the surgery and 30 days after it, before
euthanasia of the animals. The systolic blood pressure was
indirectly measured with the tail-cuff method as has been
previously described.47
Ventricular Myocyte Isolation
Rat ventricular myocytes were isolated according to the
technique previously described with some modifications.48
Briefly, the hearts were attached via the aorta to a cannula,
excised, and mounted in a Langendorff apparatus. They were
then retrograde perfused at 37°C with Krebs-Henseleit
solution (K-H) of the following composition (in mmol/L):
146.2 NaCl, 4.7 KCl, 1 CaCl2, 10 HEPES, 0.35 NaH2PO4, 1
MgSO4, and 10 glucose (pH adjusted to 7.4 with NaOH). The
solution was continuously bubbled with 100% O2. After a
stabilization period of 4 minutes, the perfusion was switched
to a nominally Ca2+-free K-H for 5 minutes. The hearts were
Clinical Perspective
What Is New?
• The protein expression and the activity of the sodium/
proton exchanger are increased in ovariectomized rats.
• The activity of the electrogenic sodium/bicarbonate
cotransporter is decreased, whereas the activity of the
electroneutral isoform is increased in ovariectomized rats.
What Are the Clinical Implications?
• These results represent a first step in the investigation of
the association of the functional changes of these trans-
porters to the cardiovascular risk during menopause and
open the possibility of implementing new strategies to
prevent or revert the development of cardiovascular
pathologies during this period.
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then recirculated with collagenase (138 units/mL) in K-H
containing 60 lmol/L CaCl2. Perfusion continued until the
hearts became flaccid (15 minutes). The hearts were then
removed from the perfusion apparatus by cutting at the
atrioventricular junction. The desegregated myocytes were
separated from the undigested tissue and rinsed several times
with a K-H solution containing 1% BSA. The CaCl2 concentra-
tion of K-H solution was increased in 4 steps to 1 mmol/L.
Myocytes were kept in 1 mmol/L CaCl2 K-H solution at room
temperature (20°C to 22°C) until use.
Platelet Isolation and Platelet pHi Measurements
Blood (7 mL) was extracted directly from the rat’s heart, mixed
with 2 mL of anticoagulant (2.5% sodium citrate, 1.5% citric
acid, and 2.0% glucose) and centrifuged at 300g for 15 min-
utes. The supernatant (platelet-rich plasma) was collected and
centrifuged (400g, 15 minutes). The pellet obtained was
washed twice with a calcium-free buffer (mmol/L: NaCl 140,
KCl 5, EGTA 0.5, acetylsalicylic acid 1, glucose 10, and HEPES
10 as well as 1% BSA; pH 7.4). After resuspension in the same
solution but without EGTA, the platelets were incubated with
the pH-sensitive fluorescent dye BCECF-AM (20 mmol/L) for
20 minutes at 37°C. The dye-loaded platelets were subjected
to intracellular acidification by preincubation with NH4Cl
(20 mmol/L, 20 minutes) and then transferred to a sodium-
free solution (mmol/L: N-methyl-D-glucamine 140, KCl 5, EGTA
0.1, MgSO4 1, glucose 10, HEPES 10, pH 7.4) until use. The
experiments were performed in the nominal absence of
bicarbonate (HEPES buffer) to ensure that the pHi recovery
after the acidic load was entirely due to NHE-1 activation. NHE-
1 was activated by reintroduction of external Na+. Aliquots of
50 lL of acidified platelet suspension were diluted in 2 mL of
HEPES buffer (mmol/L: NaCl 140, KCl 5, CaCl2 1, MgSO4 1,
glucose 10, HEPES 10, pH 7.4) in the stirred and thermally
stabilized cuvette of a spectrofluorometer (Aminco Bowman
series 2, Thermo Fisher, Waltham, MA) and excited at 503 and
440 nm; the emitted fluorescence was collected at 535 nm.
The signal at 440 nm (pHi insensitive) was used as an internal
control of platelet aggregation, and it did not show significant
changes during the experiments. The pHi recovery rate was
calculated to express NHE activity.
Calibration of the fluorescence signals was carried out in a
high-potassium nigericin solution (135 mmol/L KCl replaced
the same concentration of NaCl in the HEPES buffer) with
10 lmol/L nigericin, which balances intracellular and extra-
cellular pH.49
pHi Measurements in Isolated Myocytes
pHi was measured in single myocytes with an epifluorescence
system (Ion Optix, Milton, MA), using the previously described
BCECF technique.50 Briefly, myocytes were incubated at room
temperature for 10 minutes with 10 lmol/L BCECF-AM
followed by a 30-minute washout. Dye-loaded cells were
placed in a chamber on the stage of an inverted microscope
(Nikon TE 2000-U, Nikon, Tokyo, Japan) and continuously
superfused with 2 different solutions, 1 to measure NBC
activity, containing (mmol/L) 5 KCl, 118 NaCl, 1.2 MgSO4, 0.8
MgCl2, 1 CaCl2, 10 glucose, 20 NaHCO3, pH 7.4 after
continuous bubbling with 5% CO2 and 95% O2 and in the
continuous presence of cariporide (HOE 642) 10 lmol/L
(NHE blocker) and the other to measure NHE activity,
containing (mmol/L) 146.2 NaCl, 4.69 KCl, 11 glucose, 10
HEPES, 0.35 NaH2PO4.H2O, 1.05 MgSO47H2O, 1 CaCl2, pH
7.4. The myocytes were stimulated via 2 platinum electrodes
on either side of the bath at 0.5 Hz. Dual excitation (440 and
495 nm) was provided by a 75-W xenon arc lamp and
transmitted to the myocytes. Emitted fluorescence was
collected with a photomultiplier tube equipped with a band-
pass filter centered at 535 nm. The 495- to 440-nm
fluorescence ratio was digitized at 10 kHz (ION WIZARD
fluorescence analysis software, IonOptix, Westwood, MA). At
the end of each experiment the fluorescence ratio was
converted to pH by calibrations using the high-K+–nigericin
method.49
Ammonium Pulse
The alkalinizing transporters’ activity was assessed by eval-
uating the pHi recovery from an ammonium prepulse-induced
acute acid load. The NHE activity was evaluated using an
external solution free of bicarbonate (HEPES), whereas NBC
activity was evaluated in the presence of bicarbonate bubbled
with 95% O2/5% CO2 and HOE 642 10 lmol/L (NHE blocker).
Transient (3-minute) exposure of myocytes to 20 mmol/L
NH4Cl was used for this purpose. The dpHi/dt at each pHi,
obtained from an exponential fit of the recovery phase, was
analyzed to calculate the net H+ efflux (JH) using the following
equation: JH=btot dpHi/dt, where btot is total intracellular
buffering capacity. For HCO3 solution, btot was calculated by
the sum of the intracellular buffering due to CO2 (bCO2) plus
the intrinsic buffering capacity (bi). bCO2 was calculated as
bCO2=2.3 [HCO

3 ]i, where [HCO

3 ]i=[HCO

3 ]o 10
pHi–pHo.51,52 bi
of the myocytes was measured by exposing cells to varying
concentrations of NH4Cl in Na
+-free HEPES bathing solution.
pHi was allowed to stabilize in Na
+-free solution before
application of NH4Cl. bi was calculated from the equa-
tion bi=D[NH4
+]i/DpHi and referred to the midpoint values of
the measured changes in pHi. bi at different levels of pHi were
estimated from the least-squares regression lines of bi-versus-
pHi plots. In order to distinguish the NBC isoforms, we used a
noncommercial selective functional antibody against the
extracellular loop 3 of the NBCe1 (a-L3) generated in our
laboratory.30 In these experiments nonimmune serum was
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used as control, and serum containing the a-L3 was used to
discriminate the relative participation of both isoforms during
the recovery from the acidosis; NBCn1 activity was estimated
as the pHi recovery in the presence of a-L3, whereas NBCe1
activity was calculated as the control pHi recovery (total NBC)
minus the NBCn1 activity.30
Potassium Pulse
To investigate the NBCe1 activity in isolation we performed a
potassium pulse. Increasing extracellular K+ ([K+]o) isotonically
from 5 to 45 mmol/L produced a depolarization of 60 mV
that enhanced the NBCe1 activity and in turn elevated
pHi.
30,38 The high K+ was applied for 15 minutes, and during
this period the pHi was recorded. The HCO

3 -buffered solution
used in the K+-induced depolarization experiments contained
(mmol/L) 118 NaCl, 5 KCl, 1 MgSO4, 0.35 NaH2PO4, 10
glucose, 40 choline chloride, 20 NaHCO3, pH 7.4 after
continuous bubbling with 5% CO2 and 95% O2. K
+-induced
depolarization was assessed by replacing 40 mmol/L choline
chloride with 40 mmol/L KCl, maintaining ionic strength. The
alkalization induced by hyperkalemic solution only occurred in
the presence of extracellular sodium and bicarbonate.30
Moreover, the NHE blocker HOE 642 could not prevent the
increase in the intracellular pHi. Only the preincubation of the
myocytes with S0859 (an NBC blocker) or with the selective
NBCe1 inhibitory antibody a-L3 abolished the hyperkalemia-
induced alkalization.30
Figure 2. NHE protein expression in OVX hearts is greater than
in sham hearts. Representative immunoblots showing the
increased expression of NHE in OVX heart homogenates in
comparison to sham (SH). Average data are depicted in the bar
graphs as percentage of NHE/GAPDH respect to Sham. *P<0.05
vs Sham. N indicates number of hearts for each group; NHE,
sodium/proton exchanger; OVX, ovariectomized rats.
Table. Model Characterization
Sham OVX
DBW, g 29.23.02 (n=16) 57.14.2 (n=14)*
DSBP, mm Hg 2.72.9 (n=14) 10.233.9 (n=12)†
UW/TL, mg/cm 0.150.01 (n=13) 0.080.01 (n=14)*
HW, mg 0.880.05 (n=6) 0.890.09 (n=6)
HW/BW, mg/g 0.00430.0002 (n=6) 0.00400.0002 (n=6)
DBW indicates change in body weight between presurgical measurement and after
30 days (before use); DSBP, change in systolic blood pressure between presurgical
measurement and after 30 days (before use); HW, heart weight after euthanasia; HW/
BW, heart weight/body weight in sham and OVX rats; UW/TL, uterine weight/tibia
length.
*P<0.0001 vs sham.
†P<0.05 vs sham.
Figure 1. NHE function in OVX myocytes is increased in
comparison to sham myocytes. A, Representative traces of
intracellular pH (pHi) during the application of an ammonium pulse
(20 mmol/L NH4Cl) in sham and OVX ventricular myocytes
perfused with HEPES buffer. B, Average proton efflux (JH) carried
by NHE calculated at different pHi values during the recovery from
acidosis in sham and OVX myocytes. The values were fitted with
the following linear regression (sham: JH= 6.00pHi + 42.07; R2,
0.97; and OVX: JH= 7.85pHi + 55.53; R2, 0.99). P-value vs sham
is depicted above each average point. N indicates number or rats
for each group; NHE, sodium-proton exchanger; R2, R-Squared.
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Immunodetection
Rat hearts were homogenized, and protein was measured by
the Bradford method using BSA as standard. Samples (equal
amounts of proteins) were seeded in 8% SDS polyacrylamide
gel and transferred to polyvinylidene difluoride membranes.
Blots were probed overnight with antibodies raised against
Akt (1:1000; Cell Signaling, Danvers, MA); phospho-Ser473
Akt (P-Akt, 1:1000; Cell Signaling), NHE-1 (1:1000; Santa
Cruz Biotechnology, Dallas, TX); NBCe1 (1:1000; Millipore,
Burlington, MA), and NBCn1 (1:1000; Santa Cruz Biotechnol-
ogy). GAPDH detection (1:1000; Santa Cruz Biotechnology)
was used as a loading control. Immunoreactivity was
visualized by a peroxidase-based chemiluminescence detec-
tion kit (Immobilon Western, Millipore) using a Chemidoc
Imaging System (Bio-Rad, Hercules, CA). The signal intensity
of the bands in the immunoblots was quantified by densit-
ometry using Image J software (National Institutes of Health,
Bethesda, MD).
Statistics
GraphPad Prism 6 (GraphPad, San Diego, CA) was used for all
the statistics analysis, and OriginPro 8 (OriginLab, Northamp-
ton, MA) was used for linear fitting in Figure 1B. Data were
expressed as meansSEM. The Shapiro-Wilk test was used to
test normality. Data were compared with Student t test or t-
test with Welch’s correction if variances could not be
assumed to be equal. The number of animals (N) was used
for the statistics analysis. For the functional experiments,
each value represents an average of 1 to 5 individual
measurements (myocytes or platelets). A value of P<0.05 was
considered statistically significant (2-tailed test).
Results
Physiological Parameters
The differences in body weight and baseline systolic blood
pressure between the presurgical values and the values
1 month after surgery were significantly higher in OVX than in
sham animals (Table). As previously reported, no significant
differences in heart weight or in heart weight/body weight
Figure 3. NBC isoform activity. A, Superimposed representative
traces of intracellular pH (pHi) during the application of an
ammonium pulse in the absence (nonimmune serum as control)
or presence of the serum containing the functional inhibitory
antibody against NBCe1 (a-L3; 1:500). The experiments were
performed in the continuous presence of the NHE inhibitor HOE
642 (10 lmol/L). B, Average bicarbonate influx (JHCO3) calculated
at pHi 6.85 in the absence (control) or presence of a-L3. NBCn1
activity was estimated as the pHi recovery in the presence of a-L3,
whereas NBCe1 activity was calculated as the control pHi
recovery (total NBC) minus the NBCn1 activity. N indicates
number of rats for each group; NBCe1, electrogenic sodium-
bicarbonate cotransporter; NBCn1, neutral sodium-bicarbonate
cotransporter; OVX, ovariectomized rats.
Figure 4. NBCe1 activity is impaired in OVX myocytes. A,
Representative traces of intracellular pH (pHi) recorded in sham
and OVX ventricular myocytes during the application of a
potassium pulse (45 mmol/L K+). B, Average data of pHi
alkalinization induced by the hyperkalemic solution in sham and
in OVX myocytes. Data are expressed as increase of pHi units
after 15 minutes in comparison to the 0 time point in high-K+
solution. **P<0.01 vs sham. N indicates number of rats for each
group; NBCe1, electrogenic sodium-bicarbonate cotransporter;
OVX, ovariectomized rats.
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index were evident between groups.43,46 Uterine weight was
decreased in OVX, consistent with the lack of circulating
estrogen (Table).
Activity and Expression of NHE Are Increased in
OVX Rats
Because NHE hyperactivity or its overexpression49,53-55 has
been widely demonstrated to be involved in cardiac patholo-
gies, we decided to investigate if the function and/or protein
expression of NHE in the ventricular myocytes of the OVX rats
were also altered. As shown in the representative traces of
pHi (Figure 1A) and in the proton efflux (JH) during the
recovery from acidosis (Figure 1B), the NHE activity was
significantly increased in OVX myocytes in comparison to
sham myocytes.
In agreement with these functional results, W-B (Western-
Blot) analysis demonstrated that NHE protein expression in
OVX was significantly higher than that in sham rats (Figure 2).
Total NBC Activity Is Similar Between Sham and
OVX Myocytes, But There is a Remodeling of NBC
Isoforms
Figure 3A illustrates representative superimposed traces of
sham and OVX myocytes in the presence and absence of the
inhibitory antibody against the extracellular loop 3 of the
NBCe1 (a-L3, dilution 1/500). Figure 3B compares the JHCO3-
calculated at pHi of 6.85 in both conditions. Interestingly,
total NBC activity was similar in sham and OVX. However,
whereas NBCn1 and NBCe1 showed equivalent activity in
sham myocytes, the OVX myocytes exhibited a predominance
of NBCn1 activity. These results are in concordance with our
own data in SHR rats, which exhibit a remodeling in cardiac
NBC isoforms, resulting in a decrease of NBCe1 expression in
the cell surface and a compensatory upregulation of
NBCn1.21
In order to confirm if NBCe1 activity is impaired in OVX
myocytes, sham and OVX myocytes were exposed to a high
extracellular K+ solution. This hyperkalemic solution induced a
depolarization of the membrane potential, which, as we have
previously demonstrated, selectively stimulates NBCe1, lead-
ing to cellular alkalization.30,38 Figure 4A shows representa-
tive traces of continuous pHi recordings in sham and OVX
myocytes. As observed in the average data, NBCe1 activity is
significantly reduced in OVX myocytes (Figure 4B).
In contrast to what happened with NHE, the functional
modification in NBC isoforms was not correlated with a
variation in their total protein expression (Figure 5A and 5B).
Implications of NHE and NBC After Intracellular
Acidosis in Bicarbonate Solution
On the basis of previous experiments, we decided to
investigate if the total alkalizing transporter activity (in a
medium with bicarbonate) is increased in OVX myocytes in
comparison to the shams. Figure 6A shows representative
traces during an ammonium pulse. Figure 6B shows that the
total JH at pHi 6.85 in OVX myocytes is significantly higher in
comparison to sham ones, and, more relevant, it shows the
relative contribution of the alkalinizing transporters to the
recovery from acidosis. The NHE activity is calculated as the
Figure 5. NBC protein expression did not change between sham and OVX hearts. A, Representative
immunoblots showing the expression of NBCn1 and NBCe1 in sham and OVX heart homogenates. B,
Average data are depicted in the bar graphs as percentage of NBCn1/GAPDH or NBCe1/GAPDH relative to
sham. N indicates number of hearts for each group; NBCe1, electrogenic sodium-bicarbonate cotransporter;
NBCn1, neutral sodium-bicarbonate cotransporter; OVX, ovariectomized rats; Sh, sham.
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JH at pHi 6.85 in HCO

3 minus the JH in HCO

3 plus HOE 642.
Then, the NBCn1 activity is calculated as the JH at pHi 6.85 in
the presence of HCO3 plus HOE 642 and a-L3; and finally, the
NBCe1 activity is calculated as the JH at pHi 6.85 in HCO

3
plus HOE 642 minus that in HCO3 plus HOE 642 and a-L3.
Implications of NHE and NBC During Steady-State
pHi After Recovery From Intracellular Acidosis
We next wanted to investigate the consequence of the
modification of the alkalinizing transporters in pHi during the
steady state. As shown in Figure 7A, the final pHi reached
after recovering from the intracellular acidosis (steady state)
in extracellular HEPES solution (where the only active
alkalinizing transporter is the NHE) is significantly higher in
OVX myocytes in comparison to the shams. On the other
hand, the steady-state pHi in the presence of extracellular
HCO3 , where both the NHE and the NBC isoforms are active,
is similar between those 2 groups (Figure 7B). Note that the
maximal acidification with or without bicarbonate was similar
in OVX and sham rats (Figure 7C and 7D), ruling out that the
activity of the alkalinizing transporters could be influenced by
an initial different pHi.
Role of Akt in NHE and NBC Isoform Remodeling
Because Akt is an important molecule that has been involved
in several protective intracellular pathways of estrogens, we
aimed to investigate whether the amount of p-Akt is impaired
in OVX hearts and if this impairment is interfering in the
physiologic Akt-induced NHE and NBCe1 regulation. We
measured p-Akt in sham and OVX hearts. Figure 8 exhibits
representative W-B and the average data, which clearly
illustrate that p-Akt is decreased in OVX hearts.
NHE Activity in Platelets as a Potential Biomarker
We finally attempted to further evaluate if NHE activity in
platelets might reflect the cardiac NHE performance.
Figure 9A shows representative traces during the pHi
recovery. The average data demonstrated that, in concor-
dance with the cardiac NHE, the NHE activity in OVX
platelets is significantly higher than that observed in sham
platelets (Figure 9B).
Discussion
The present work demonstrated for the first time that cardiac
ventricular myocytes of OVX rats have several alterations in
the major alkalinizing transporters (NHE and NBC) involving
an increase in NHE activity and protein expression and a
remodeling of NBC isoforms (decreased NBCe1 activity and
higher NBCn1 activity).
It is well known that the NHE overexpression and/or its
hyperactivity are associated with the development and
progression of cardiac diseases. It has been demonstrated
that the activation of NHE leads to an increase in intracellular
sodium concentration, which activates the reverse mode of
the Na+/Ca2+ exchanger (rNCX), enhances the intracellular
calcium concentration ([Ca2+]i), and finally leads to cell
growth.24,25,56 NBC has been associated with cardiac
pathologies as a consequence of a similar pathway.57-59
Interestingly, the existence of 2 functional isoforms (NBCn1
and NBCe1) makes it necessary to evaluate them as
independent transporters. In this regard it has been proposed
that NBCn1 hyperactivity, similarly to NHE hyperactivity, is
harmful because it leads to sodium and calcium overload. In
opposition, NBCe1 activity might be beneficial for myocyte
Figure 6. Relative contribution of the transporters to the pHi
recovery in bicarbonate solution. A, Representative traces of
intracellular pH (pHi) during the application of an ammonium pulse
(20 mmol/L NH4Cl) in sham and OVX ventricular myocytes
perfused with bicarbonate buffer. B, Average bicarbonate influx
(JHCO3-) at pHi 6.85 in sham and OVX myocytes, evidencing the
relative contributions of NHE, NBCn1, and NBCe1 to the total
recovery. *P<0.05 vs sham. N indicates number of rats for each
group; NHE, sodium/proton exchanger; NBCe1, electrogenic
sodium-bicarbonate cotransporter; NBCn1, neutral sodium-bicar-
bonate cotransporter; OVX, ovariectomized rats.
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physiology.33 NBCe1 could be claimed as a “Na-sparing”
mechanism because, based on its stoichiometry, it introduces
less sodium into the myocyte per molecule of bicarbon-
ate.19,21 Moreover, because the NBCe1 generates an anionic
current that shortens the action potential, the reduced
duration of phase 2, the plateau, of the action potential
would lead to less calcium entrance, preventing its overload
and the development of cardiac hypertrophy.60 In this regard
we have provided evidence that in SHR rats the NBCe1
activity is decreased, and this is compensated for by an
overexpression of NBCn1.21 We suggested that this remod-
eling might explain the development and/or progression of
the cardiac hypertrophy of SHR.21 The results presented in
this work allow us to speculate that the NHE overexpression,
accompanied with the impairment of NBCe1 activity, might be
deleterious for OVX myocytes and might explain, at least in
part, several cardiovascular abnormalities reported in OVX
rats.39,40,45,46
It has been previously demonstrated that NHE hyperactiv-
ity is associated with the development of cardiac hypertro-
phy.23-25,54 In the present work we did not find a significant
difference in heart weight between sham and OVX rats. One
possibility of such a discrepancy is the difference in sex
because the majority of research was done in male animals.
Moreover, similar to our findings, it has been demonstrated
that OVX rats did not develop cardiac hypertrophy.43,46 In
contrast, Wang et al, using oophorectomized mRen2.Lewis
rats, demonstrated an increase in the ratio of heart weight/
tibia length.42 The explanation for this controversy is not
apparent to us. It might be possible that the differential
background of the rats affects the cardiac growth. Regarding
this, the mRen2.Lewis strain has a genetic modification in the
renin-angiotensin-aldosterone system that converts them in
an estrogen-sensitive model. In our case we use young Wistar
rats that do not have any pathology or alteration previous to
the ovariectomy. Moreover, the time between the surgery and
Figure 7. The modifications of the alkalinizing transporters lead to an increase in the pHi during the
steady-state only in HEPES buffer. A, Average final pHi after the ammonium pulse in HEPES buffer in sham
and OVX ventricular myocytes. B, Average final pHi after the ammonium pulse in bicarbonate buffer in sham
and OVX ventricular myocytes. C, Maximal acidification during the ammonium pulse in HEPES buffer in
sham and OVX ventricular myocytes. D, Maximal acidification during the ammonium pulse in bicarbonate
buffer in sham and OVX ventricular myocytes. *P<0.05 vs sham. N indicates number of rats for each group;
OVX, ovariectomized rats.
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euthanasia might be important. Whereas Wang et al waited
3 months to use the rats after the ovariectomy, in the present
work we used the rats only 1 month after the surgery. It might
be possible that although NHE activity had already increased
in our OVX rats, 1 month was not sufficient time for our OVX
rats to develop cardiac hypertrophy. Last, although we found
a significant increase in the systolic blood pressure in the OVX
rats versus the shams, the increase did not reach hyperten-
sive values.
The overexpression of the NHE accompanied with its
upregulation in different models of CVD has been previously
reported.49,53-55 Interestingly, our results obtained in OVX rats
showed the same behavior. On the other hand, in the present
work, we observed a decreased activity of the NBCe1 that
was not accompanied by a decrease in the protein expression.
Similarly, in SHR rats the NBCe1 protein expression is higher
in comparison to their control, whereas its activity is
decreased, suggesting that there is a disturbance in NBCe1
protein trafficking.21 More experiments are needed to clarify if
this situation is taking place in the OVX rats.
Interesting as well, during the steady state reached after
recovery from the intracellular acidosis, the pHi is higher in
the OVX rats only in the absence of extracellular bicarbonate,
indicating that the NHE activity is increased. On the other
hand, in the presence of bicarbonate the pHi at the steady
state is similar between OVX and sham rats, suggesting that
the acidifying transporters (ie, the Cl/HCO3 exchanger or
anion exchanger) might compensate for the increase in NHE
activity. Although little is known about the regulation of the
acidifying transporters during menopause, these results
suggest that they might be upregulated, minimizing the NHE
effect on pHi. Similar results were demonstrated in SHR.
49
Nevertheless, the putative intracellular sodium overload due
to the enhanced NHE activity cannot be compensated for by
the activation of the anion exchanger, whose function is not
coupled to sodium. Further experiments are needed in order
to confirm this speculation.
It has been previously demonstrated that Akt is part of the
intracellular signaling of estrogen-induced cardioprotection.34
Moreover, it has been described that p-Akt inhibits NHE,35,36
whereas it stimulates NBCe1.37,38 Our results show that p-Akt
is diminished in OVX hearts, perhaps due to the decrease in
plasmatic estrogen levels after ovariectomy. Although the
Figure 8. p-Akt expression: representative immunoblots show-
ing the expression of p-Akt in sham and OVX heart homogenates.
Average data are depicted in the bar graphs as percentage of p-
Akt/Akt relative to sham. To normalize the amount of the
phosphorylated proteins, the membranes were stripped and
probed with an antibody that specifically detects total Akt.
*P<0.05 vs sham. N indicates number of hearts for each group;
OVX, ovariectomized rats; SH, sham.
Figure 9. Platelets NHE activity. A, Representative traces of pHi recorded in platelets during the recovery
of an ammonium pulse in platelets perfused with HEPES buffer. B, Average rate of recovery from acidosis,
depicted as change in pH units per minute at pHi 6.8. *P<0.05 vs sham. N indicates number of rats for each
group; NHE, sodium/proton exchanger; OVX, ovariectomized rats.
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results presented herein represent a potential chronic effect
of the reduction of p-Akt levels, and the regulation of the
alkalinizing transporters by this kinase was reported as an
acute effect, we can speculate that the decrease in p-Akt
levels in the OVX rats might explain, at least in part, the NHE
upregulation and the impaired NBCe1 function.
Previous studies performed in hypertensivemodels reported
enhanced NHE activity in different blood cell types, including
platelets.61,62 Furthermore, the enhanced activity of this
transporter in these cells seems to be a reflection of the
increased cardiac NHE activity that is associated with different
cardiac pathologies, including the maladaptive hypertrophy
induced by hypertension. Although themeasurement of cardiac
transporter activity in vivo is complicated, the possibility of
having an indirect approximation that could be used as a
potential biomarker of the progression of the cardiac alter-
ations triggered by menopause deserves to be highlighted.
This is the first time that a cellular alteration in the cardiac
alkalinizing transporters has been shown during menopause.
The results presented herein might represent the first step in
the investigation of the association of the functional changes
of these transporters to cardiovascular risk during meno-
pause. Moreover, we think that more studies evaluating the
potential effect of chronic treatment with estrogens prevent-
ing these intracellular changes would be relevant to the
knowledge about this physiological condition.
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